Isothiocyanate-mediated cyclization of phage-displayed peptides enables discovery of macrocyclic binders
Open Access
- 6 February 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (6) , eaeb7086
Abstract
Cyclic peptides exhibit advantages in binding protein targets with high affinity and competency in inhibiting protein-protein interactions. Cyclic peptide phage display with more than a billion variants is an invaluable tool in drug discovery. However, achieving efficient peptide cyclization on phages remains a challenge because of the limited availability of reaction sites, which also restrict scaffold diversity. Here, we report an isothiocyanate-derived cross-linker featuring dual reactive groups: a bromide that covalently attaches to cysteine thiols and a thiocyanogen that selectively forms a thiourea bridge with either the N-terminal amino group or ε-amines of lysine, depending on pH. This strategy enables pH-modulated cyclization. At pH 6.5, head–to–side chain cyclization occurs, and at pH 9.5, side chain–to–side chain ligation is performed. Both processes simultaneously generate thiourea scaffolds. To demonstrate the versatility and biocompatibility of this approach, we constructed cyclic peptide libraries using both cyclization methods and successfully selected binders for several targets, including cyclophilin D, murine double minute 2, and Keap1, with dissociation constants ranging from micromolar to nanomolar. Given the broad pharmacological potential of the thiourea moiety, this phage display library opens previously unidentified chemical space with high scaffold diversity and the integration of a proven pharmacophore for the development of cyclic peptide therapeutics.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (22ZD6FA006, 23ZDFA015, 24ZD13FA017)
- National Natural Science Foundation of China (22277099)
This publication has 60 references indexed in Scilit:
- Genetic Incorporation of a Reactive Isothiocyanate Group into ProteinsAngewandte Chemie International Edition, 2016
- Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agentsActa Pharmaceutica Sinica B, 2015
- Designer macrocyclic organo-peptide hybrids inhibit the interaction between p53 and HDM2/X by accommodating a functional α-helixChemical Communications, 2014
- Modular Assembly of Macrocyclic Organo–Peptide Hybrids Using Synthetic and Genetically Encoded PrecursorsAngewandte Chemie International Edition, 2011
- Phage-encoded combinatorial chemical libraries based on bicyclic peptidesNature Chemical Biology, 2009
- N‐Terminal Protein Modification through a Biomimetic Transamination ReactionAngewandte Chemie International Edition, 2006
- Isothiocyanates: mechanism of cancer chemopreventive actionAnti-Cancer Drugs, 2002
- ISOTHIOCYANATE COMPOUNDS AS FLUORESCENT LABELING AGENTS FOR IMMUNE SERUM1958
- A method for the determination of amino acid sequence in peptides.1949
- A note on the combination of cysteine with allyl isothiocyanateBiochemical Journal, 1937